Pharma
Maxion Therapeutics welcomes Dr Arndt Schottelius as new CEO
Maxion Therapeutics, the biotechnology company developing antibody-based drugs for previously untreatable ion channel- and GPCR-driven diseases, announces that Dr Arndt Schottelius has been appointed as the new Chief Executive Officer, effective on 1 March 2024, to take the Company to i...
SciTribe logo design
Angie Moyes writes...I worked with Dr Priya Kalia on her ‘SciTribe’ logo. Priya knew that she wanted a typewriter font and came to me to further develop the idea. Priya wanted her branding to feel more ‘together’ as her business, that offers strategic communications consulting focused o...
EUROAPI UK switches on to renewable energy
Euroapi UK has switched on their solar farm, generating renewable energy to sustain the manufacturing facility for the next 30 years. ...
CDMO: EUROAPI completes acquisition of Biano
CDMO: EUROAPI completes acquisition of Biano Paris – November 21, 2023 – EUROAPI today announced the completion of the acquisition of BianoGMP (“Biano”), strengthening its CDMO expertise in the high-growth oligonucleotide market. This acquisition further differentiates EUROAPI’s value...
EUROAPI enhances its CDMO capabilities through a pivotal collaboration with SpiroChem, a leading Contract Research Organization (CRO)
This collaboration will ensure the continuity of API development, from route scouting to process industrialization and GMP manufacturing EUROAPI and SpiroChem to provide clients with consolidated CRO-CDMO customized solutions to accelerate API chemical development and shorten timelines,...
Impact of the EU's general pharmaceutical legislation on Europe's innovation ecosystem and biotechnology companies
EuropaBio asked Charles River Associates to research the potential impact of the proposed changes included within the EU’s General Pharmaceutical Legislation (GPL) to Europe’s innovation ecosystem, with a particular focus on its impact on the growth of emerging and small biotechnology c...
The emerging business models for digital therapeutics
This article was originally published at Med Device Online. Digital therapeutics (DTx) leverage technology to deliver evidence-based treatments for various health conditions, aiming to complement or replace traditional treatments with personalized, scalable, and cost-effective int...
Flare V8: What's new in Cresset’s molecular modeling software?
Date: Thursday 22nd February 2024 Time: 3pm GMT / 4pm CET / 10am EDT / 7am PST Duration: 45 minutes Format: Webinar Please note that this webinar will be replayed on Friday 23rd February for the APAC region (3:30pm IST). Register here. Abstract Flare V8 is available now! Join us...
Don't miss your chance to enter the Cambridge Independent Science and Technology Awards 2024
The deadline is January 31.
New NHS blood group genotyping test developed with BioResource launches today
From today, almost 18,000 people in England with sickle cell disorder and thalassaemia can have a world-first genetic test to better match future blood transfusions, reducing the risk of side effects. ...